| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.2 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.2 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.2 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |